Views & Analysis A new dawn for clinical trial management It’s time for pharma to take a 360-degree view of its clinical trial data and step into the future with near real-time trial management.
R&D Dangerous data delays – a real-time problem Delayed clinical trial data delivery is a growing problem for pharmaceutical companies and one that can have catastrophic consequences for the development of their promising pipeline candid
R&D Is a lack of real-time data holding trials back? It’s 2020 and the digital revolution is well on its way.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.